An application on breast cancer life insurance and critical illness insurance
Duration of the Project: 2022 – 2024 (currently underway)
The project is led by Heriot-Watt University and primarily managed by Research Fellow Arık Ayşe, with support from Professor of Statistics George Streftaris, both of the Department of Actuarial Mathematics and Statistics, Heriot-Watt University, and the Maxwell Institute for Mathematical Sciences, UK.
The project is associated with ongoing research focusing on results dissemination, knowledge exchange, and conference presentations.
Steering committee
Foundation: Zeying Peuillet and Adam Shao
Heriot-Watt University: Ayse Arik and George Streftaris
The main objectives of the related research project are to:
- investigate how the COVID-19 pandemic, and its impact on the diagnosis of different stages of breast cancer (BC) morbidity, have affected BC mortality;
- assess the implications of COVID-related changes to BC morbidity and mortality on related life and critical illness insurance (CII) products; and
- disseminate the findings to a wider community, including academic and industry parties.
The project outputs will be submitted for publication in leading international research journals, while also being presented at international conferences and seminars.
---------------------------------------------------------------------
- The effect of the COVID-19 health disruptions on breast cancer mortality for older women: a semi-Markov modelling approach - View Webpage - Article (Scandinavian Actuarial Journal) - May 13, 2024
- Exploring key drivers in cancer risk: Unveiling disparities - Presentation - Video - Workshop in Paris - March 4, 2024
- Intermediary Report - November 27, 2023
- Cancer, COVID-19 and Inequalities - Webinar - November 15, 2023
- Estimating the impact of the COVID-19 pandemic on breast cancer - Workshop in Paris - September 20, 2023
- View the 2023 Living to 100 Research Symposium presentation - April 20, 2023